Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
Acta Cardiol. 2024 May;79(3):267-273. doi: 10.1080/00015385.2023.2246200. Epub 2023 Aug 22.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was the main pathogen in the COVID-19 pandemic. This viral infection has been associated with several respiratory and non-respiratory complications contributing to a higher mortality rate, especially in patients with underlying heart diseases worldwide. Once considered a respiratory tract disease, it is now well-known that COVID-19 patients may experience a wide range of cardiac manifestations. Because of its remarkable direct and indirect effects on the cardiovascular system, herein, we examined the published literature that studied the hypothetical mechanisms of injury, manifestations, and diagnostic modalities, including changes in molecular biomarkers with a predictive value in the prognostication of the disease, as well as emerging evidence regarding the long-term cardiac complications of the disease.
严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）是 COVID-19 大流行的主要病原体。这种病毒感染与多种呼吸系统和非呼吸系统并发症有关，导致全球死亡率上升，特别是在有基础心脏病的患者中。COVID-19 最初被认为是一种呼吸道疾病，但现在已经很清楚，COVID-19 患者可能会出现多种心脏表现。由于它对心血管系统有显著的直接和间接影响，因此，我们查阅了已发表的文献，研究了损伤、表现和诊断方式的假设机制，包括具有疾病预后预测价值的分子生物标志物的变化，以及关于该疾病的长期心脏并发症的新证据。
